1
|
Karthikeyan S, Sundaramoorthy A, Kandasamy S, Bharanidharan G, Aruna P, Suganya R, Mangaiyarkarasi R, Ganesan S, Pandian GN, Ramamoorthi A, Chinnathambi S. A biophysical approach of tyrphostin AG879 binding information in: bovine serum albumin, human ErbB2, c-RAF1 kinase, SARS-CoV-2 main protease and angiotensin-converting enzyme 2. J Biomol Struct Dyn 2024; 42:1455-1468. [PMID: 37114656 DOI: 10.1080/07391102.2023.2204368] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Accepted: 04/01/2023] [Indexed: 04/29/2023]
Abstract
Viral infections cause significant health problems all over the world, and it is critical to develop treatments for these problems. Antivirals that target viral genome-encoded proteins frequently cause the virus to become more resistant to treatment. Because viruses rely on several cellular proteins and phosphorylation processes that are essential to their life cycle, drugs targeting host-based targets could be a viable treatment option. To reduce costs and improve efficiency, existing kinase inhibitors could be repurposed as antiviral medications; however, this method rarely works, and specific biophysical approaches are required in the field. Because of the widespread use of FDA-approved kinase inhibitors, it is now possible to better understand how host kinases contribute to viral infection. The purpose of this article is to investigate the tyrphostin AG879 (Tyrosine kinase inhibitor) binding information in Bovine Serum Albumin (BSA), human ErbB2 (HER2), C-RAF1 Kinase (c-RAF), SARS-CoV-2 main protease (COVID 19), and Angiotensin-converting enzyme 2 (ACE-2).Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Subramani Karthikeyan
- Division of Physics, School of Advanced Sciences, Vellore Institute of Technology University, Chennai, India
| | | | | | | | | | | | | | | | - Ganesh N Pandian
- Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan
- Department of Molecular Engineering, Kyoto University, Kyoto, Japan
| | | | - Shanmugavel Chinnathambi
- Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan
| |
Collapse
|
2
|
Karthikeyan S, Grishina M, Kandasamy S, Mangaiyarkarasi R, Ramamoorthi A, Chinnathambi S, Pandian GN, John Kennedy L. A review on medicinally important heterocyclic compounds and importance of biophysical approach of underlying the insight mechanism in biological environment. J Biomol Struct Dyn 2023; 41:14599-14619. [PMID: 36914255 DOI: 10.1080/07391102.2023.2187640] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Accepted: 02/12/2023] [Indexed: 03/16/2023]
Abstract
Heterocyclic derivatives have more interesting biological properties which hold a remarkable place in pharmaceutical industries due to their unique physiochemical properties and ease of adaption in various biological environments. Of many, the above-said derivatives have been recently examined for their promising action against a few malignancies. Specifically, anti-cancer research has benefited from these derivatives' natural flexibility and dynamic core scaffold. In any case, concerning some other promising anti-cancer drugs, heterocyclic derivative doesn't come without deficiencies. To be a successful drug candidate it should poses Absorption, Distribution, Metabolism and Eliminations (ADME) parameter, and must also have good binding interaction towards carrier protein as well as DNA and less in toxic nature, economically feasible. In this review, we described the overview of biologically important heterocyclic derivatives and their main application in medicine. Further, we focus types of biophysical techniques to understand the binding interaction mechanism.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Subramani Karthikeyan
- Division of Physics, School of Advanced Sciences, Vellore Institute of Technology University, Chennai, India
- Centre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology University, Chennai, India
| | - Maria Grishina
- Laboratory of Computational Modelling of Drugs, South Ural State University, Chelyabinsk, Russia
| | | | | | - Anitha Ramamoorthi
- Department of Chemistry, Velammal Intitute of Technology, Velammal Knowledge Park, Panchetti, India
| | - Shanmugavel Chinnathambi
- Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan
| | - Ganesh N Pandian
- Institute for Integrated Cell-Material Sciences, Institute for Advanced Study, Kyoto University, Kyoto, Japan
- Department of Molecular Engineering, Kyoto University, Kyoto, Japan
| | - L John Kennedy
- Division of Physics, School of Advanced Sciences, Vellore Institute of Technology University, Chennai, India
| |
Collapse
|